FDA 510(k)

Quantum Mitohormesis (QMT) (M2101)

K-번호: K240348 · 2024-12-19

결정일2024-12-19

제품 코드IPF

자문 위원회PM

결정Substantially Equivalent

기기 요약

Quantum Mitohormesis (QMT) (M2101) is the device name listed in this FDA 510(k) record. The listed applicant is Quantumtx Pte. , Ltd.. It received FDA 510(k) clearance on 2024-12-19 under 510(k) number K240348. The device is classified under product code IPF. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

자주 묻는 질문

What is the Quantum Mitohormesis (QMT) (M2101)?

Quantum Mitohormesis (QMT) (M2101) is a medical device that received FDA 510(k) clearance on 2024-12-19. The listed applicant is Quantumtx Pte. , Ltd.. The 510(k) number is K240348.

When did Quantum Mitohormesis (QMT) (M2101) receive FDA 510(k) clearance?

Quantum Mitohormesis (QMT) (M2101) received FDA 510(k) clearance on 2024-12-19, under 510(k) number K240348.

Who is the listed applicant for Quantum Mitohormesis (QMT) (M2101)?

The FDA 510(k) record lists Quantumtx Pte. , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Quantum Mitohormesis (QMT) (M2101)?

The FDA product code for Quantum Mitohormesis (QMT) (M2101) is IPF.

공식 출처

FDA 데이터베이스에서 보기 →

FDA Open API에서 수집된 데이터입니다. 가장 정확하고 공인된 정보는 항상 공식 레코드를 참조하시기 바랍니다.

Quantum Mitohormesis (QMT) (M2101)

기기 요약

자주 묻는 질문

관련 임상시험

관련 기기 (코드: IPF)

공식 출처